Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 3271 entries
Sorted by: Best Match Show Resources per page
Calcium supplementation and bone loss in postmenopausal women.

[No authors listed]
PMID: 2046980
Nutr Rev. 1991 Jun;49(6):184-7. doi: 10.1111/j.1753-4887.1991.tb03016.x.

No abstract available.

Role of oestrogen in the development of osteoporosis.

Hillard TC, Stevenson JC.
PMID: 1933600
Calcif Tissue Int. 1991;49:S55-9. doi: 10.1007/BF02555090.

The evidence now strongly supports a central role for oestrogen in the maintenance of the normal female skeleton. Loss of endogenous oestrogen leads to a period of accelerated bone loss which can be prevented with appropriate oestrogen replacement. The...

[Principles of estrogen therapy].

Schneider HP.
PMID: 2686563
Arch Gynecol Obstet. 1989;246:S76-84. doi: 10.1007/BF00935857.

No abstract available.

Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy.

Tosteson AN, Rosenthal DI, Melton LJ, Weinstein MC.
PMID: 2119161
Ann Intern Med. 1990 Oct 15;113(8):594-603. doi: 10.7326/0003-4819-113-8-594.

Bone mass measurement at menopause to identify and selectively prescribe hormone replacement therapy for women at high risk for fractures has seen limited clinical use. We used epidemiologic, clinical, and economic data in a decision-analytic model to compare the...

Effects on bone of surgical menopause and estrogen therapy with or without progesterone replacement in cynomolgus monkeys.

Jayo MJ, Weaver DS, Adams MR, Rankin SE.
PMID: 2386153
Am J Obstet Gynecol. 1990 Aug;163(2):614-8. doi: 10.1016/0002-9378(90)91212-u.

The influence of estrogen replacement therapy on bone loss of surgically postmenopausal cynomolgus macaques was evaluated histomorphometrically using the first (L-1) lumbar vertebra and ex vivo dual photon absorptiometry of the third (L-3) lumbar vertebra. The animals were a...

Postmenopausal osteoporosis. Part 1.

Horowitz M, Need AG, Morris HA, Nordin BE.
PMID: 2049002
Aust Fam Physician. 1991 Apr;20(4):494, 496, 498-9.

No abstract available.

[Prevention of secondary manifestations of menopause. Perspectives and alternatives].

Welti HJ.
PMID: 2686565
Arch Gynecol Obstet. 1989;246:S92-7. doi: 10.1007/BF00935859.

No abstract available.

Prevention of osteoporosis. Current recommendations.

Ellerington MC, Stevenson JC.
PMID: 1493354
Drugs Aging. 1992 Nov-Dec;2(6):508-17. doi: 10.2165/00002512-199202060-00006.

Osteoporosis and its treatment have attracted much attention in recent years, especially since the widespread recognition of its association with the menopause. The resulting fractures are a cause of considerable morbidity and mortality in the elderly, and current costs...

Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.

Balfour JA, McTavish D.
PMID: 1493353
Drugs Aging. 1992 Nov-Dec;2(6):487-507. doi: 10.2165/00002512-199202060-00005.

The estradiol transdermal therapeutic system is a percutaneous delivery device which, when affixed to the skin, delivers estradiol (the major estrogen in premenopausal women) into the systemic circulation at a constant rate for up to 4 days. Because this...

[Favorable effects of oral estrogen-progestin contraception].

Presl J.
PMID: 1815841
Cesk Gynekol. 1991 Nov;56(5):350-2.

No abstract available.

If my wife had osteoporosis.

Francis RM.
PMID: 2611114
Br J Clin Pract. 1989 Mar;43(3):109-11.

No abstract available.

Clinical review 8: Clinical heterogeneity of involutional osteoporosis: implications for preventive therapy.

Riggs BL, Melton LJ.
PMID: 2186052
J Clin Endocrinol Metab. 1990 May;70(5):1229-32. doi: 10.1210/jcem-70-5-1229.

No abstract available.

Showing 1 to 12 of 3271 entries